NCT05534594
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Medullary, +20 more
- Locations
-
- University Medical Centre Groningen Groningen, Provincie Groningen, Netherlands
Clinical trial condition
Medullary Thyroid Cancer
Explore clinical trials studying Medullary Thyroid Cancer. Study availability and eligibility vary by location and protocol.
24 public trials
6 recruiting studies
Medullary Thyroid Cancer trial results
NCT03037385
- Conditions
- Adenocarcinoma, Adenocarcinoma, Papillary, Bronchial Diseases, +55 more
- Locations
-
- Mayo Clinic Hospital Phoenix, Arizona, United States
- UC Irvine Medical Center Orange, California, United States
- University of Colorado Anschutz Medical Campus Aurora, Colorado, United States
- Georgetown University Medical Center Washington D.C., District of Columbia, United States
NCT06292988
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Medullary, +10 more
- Locations
-
- Oregon Health & Science University, Oregon Oregon City, Oregon, United States
- Department of Surgery, Saint John of God Hospital, Salzburg, Austria Salzburg, Austria
- Saint Luc, University Clouvain, Belgium Brussels, Belgium
- Head and Neck Surgery Department, Hospital Ana Nery, Santa Cruz do Sul, Brazil Santa Cruz do Sul, Brazil
NCT06243965
- Conditions
- Adenocarcinoma, Brain Diseases, Brain Neoplasms, +33 more
- Locations
-
- Fondazione Policlinico Universitario Agostino Gemelli IRCCS Rome, Italy
NCT02465424
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Medullary, +10 more
- Locations
-
- Velindre Hospital Cardiff, United Kingdom
- University Hospitals of Coventry and Warwickshire Coventry, United Kingdom
- Western general Hospital Edinburgh, United Kingdom
- Imperial Hospital London, United Kingdom
NCT01539655
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Medullary, +10 more
- Locations
-
- Research Site Overland Park, Kansas, United States
NCT01757470
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Medullary, +10 more
- Locations
-
- Research Site Montreal, Quebec, Canada
NCT01625520
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Medullary, +10 more
- Locations
-
- Department of Molecular and Clinical Endocrinology and Oncology, "Federico II" University of Naples Naples, Italy
Active, Not Recruiting
A Study of Selpercatinib (LY3527723) in Participants With Advanced Solid Tumors Including RET Fusion-positive Solid Tumors, Medullary Thyroid Cancer and Other Tumors With RET Activation
NCT04280081
- Conditions
- Adenocarcinoma, Bronchial Neoplasms, Carcinoma, +25 more
- Locations
-
- Beijing Cancer Hospital Beijing, Beijing Municipality, China
- The First Affiated Hospital Of Guangzhou Medical University Guangzhou, Guangdong, China
- Southern Medical University Nanfang Hospital Guangzhou, Guangdong, China
- Hunan Cancer Hospital Changsha, Hunan, China
Active, Not Recruiting
A Study of Selpercatinib (LOXO-292) in Participants With Advanced Solid Tumors, RET Fusion-Positive Solid Tumors, and Medullary Thyroid Cancer (LIBRETTO-001)
NCT03157128
- Conditions
- Adenocarcinoma, Adenocarcinoma, Papillary, Any Solid Tumor, +46 more
- Locations
-
- Mayo Clinic of Scottsdale Scottsdale, Arizona, United States
- City of Hope National Medical Center Duarte, California, United States
- UCLA Medical Center Los Angeles, California, United States
- Hoag Memorial Hospital Presbyterian Newport Beach, California, United States